Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
In Plain Cite is a podcast about developments in federal criminal defense law, focusing on the US Supreme Court and the Fourth Circuit Court of Appeals, produced by the Federal Public Defender Office in the Southern District of West Virginia.
…
continue reading
Église chrétienne | Christian church
…
continue reading
Cité Radieuse c’est quoi ? Une rencontre, une conversation avec des personnes inspirantes venant d’horizons très divers mais qui ont en commun de faire rayonner une ville : Marseille ! Elles y vivent, y ont vécu ou tout simplement l’aiment pour ce qu’elle a à offrir : Marseille est lumineuse, bouillonnante, arlequinée, agitée, on l’aime autant qu’on la déteste ... parfois ! Parfois seulement ! Je suis Caroline Bindel, journaliste basée à Marseille. Bienvenue dans Cité Radieuse ! Hébergé par ...
…
continue reading
…
continue reading
Experts shape our world. Sometimes for the better, sometimes for the worse. In every big story, you’ll find one; you’ll find a researcher, scientist, engineer, planner, policy wonk, data nerd, bureaucrat, regulator, intellectual, or pseudointellectual. Their ideas are often opaque, unrecognized, and difficult to understand. Some of them like it that way. On Cited, we reveal their hidden stories.
…
continue reading
Le podcast pour une vie plus simple et sereine dans le monde moderne. Minimalisme, slow, écologie, simplicité volontaire...
…
continue reading
Le sacré et la cité tente de répondre à de grandes questions touchant le phénomène religieux dans notre société. Des questions de fond posées avec ouverture et sans complaisance par la communicatrice en histoire Myriam Wojcik. Une série qui vise à briser certains mythes et tabous.
…
continue reading
The Cite Black Women podcast is a periodic program with a simple message: Cite Black Women. We have been producing knowledge since we blessed this earth. We theorize, we innovate, we revolutionize the world. We do not need mediators. We do not need interpreters. It's time to disrupt the canon. It's time to upturn the erasures of history. It's time to give credit where credit is due. This bi-weekly podcast features reflections and conversations about the politics and praxis of acknowledging a ...
…
continue reading
The "Cite of the Crime" Podcast is a biweekly Florida and Federal criminal case law update show for criminal defense attorneys, prosecutors, judges and anybody who is interested in criminal law case law in the Florida District Courts, the Florida Supreme Court, the Eleventh Circuit Court of Appeals and the U.S. Supreme Court. Each week, criminal defense attorney, Jeremy Lasnetski of Shorstein, Lasnetski, & Gihon reviews the previous weeks Florida DCA and Florida Supreme Court cases and in a ...
…
continue reading
1
Ep 88 June 2024 Fourth Circuit and Supreme Court Update
24:55
24:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
24:55
Jonathan Byrne and Jackie Tarlton of the Eastern District of North Carolina Federal Public Defender Office discuss recent Fourth Circuit and Supreme Court news.
…
continue reading
1
#72 - Lili Sohn - Autrice et dessinatrice de BD !
29:27
29:27
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
29:27
Alors ?! Vous en pensez quoi de cette nouvelle identité sonore ?! J’espère qu’elle vous plait autant qu’à moi car après avoir posté 70 épisodes j’avais envie de changement, de renouvellement même si évidemment sur le fond rien ne bouge : Marseille reste le fil rouge de mes rencontres ! Marseille bouillonnante, arlequinée, agitée ;)) Et c’est un bon…
…
continue reading
1
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
22:44
22:44
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:44
In this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.Talent acquis…
…
continue reading
1
June 2024 Datamonitor Healthcare Podcast: ASCO 2024
43:35
43:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
43:35
The oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 2024 conference.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS…
…
continue reading
1
China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)
27:10
27:10
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
27:10
Guest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, updates to the planned US BIOSECURE Act and industry preparations for its impact. Dexter also discusses China biotech's data highlights from ASCO 2024.Par Citeline
…
continue reading
글로벌 제약업계는 암 연구의 미래를 어떻게 보고 있을까? Scrip의 ASCO 현장 취재 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150378/ASCO-Roundup-Looking-For-The-Future-Of-Cancer-ResearchPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniPar Citeline
…
continue reading
1
Scrip's Five Must-Know Things - 10 June 2024
15:38
15:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:38
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup; data on Carvykti in community at ASCO; strong new results for tirzepatide in MASH; and orphan slowdown signals new path ahead.https://scrip.citeline.com/SC150401/Quick-Listen-Scrips-Five-MustKnow-Thi…
…
continue reading
1
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
24:18
24:18
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
24:18
Generics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explaining the recent debate over US patent listings in the FDA's Orange Book.Par Citeline
…
continue reading
1
China Biotech Podcast - 5 June 2024 (Chinese language)
23:09
23:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
23:09
Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks at Chinese biotechs going global, and the opportunities and challenges in the latest industry latest trends.https://scrip.citeline.com/SC150370/China-Biotech-Podcast-Going-Global-Trends-Rare-Disease-Dr…
…
continue reading
1
JB CEO On CDMO Growth, Red Sea Crisis And More
34:06
34:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
34:06
In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, recent acquisitions, including from Novartis, as well as JB's ambitions to ramp up the cardiology segment and its CDMO business, which already has major clients including J&J.https://scrip.citeline.co…
…
continue reading
1
Scrip's Five Must-Know Things - 3 June 2024
15:09
15:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:09
Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US acquisition; Novartis aims for renal disease dominance; paying for gene therapies; and US BIOSECURE Act diluted.https://scrip.citeline.com/SC150361/Quick-Listen-Scrips-Five-MustKnow-ThingsPlaylist: http…
…
continue reading
1
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse
22:15
22:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:15
An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-focused biotech company so far, and its plans for future expansion.Par Citeline
…
continue reading
1
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone
50:18
50:18
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
50:18
In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer healthcare companies need to know about this enormously complex and significant piece of EU legislation.3:30 Introduction to the CSRD7:45 What companies are affected by the CSRD15:00 Sp…
…
continue reading
1
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
37:01
37:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:01
Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delatte, PhD, Vice President at Allucent and Harshini Neelakantan, Executive Director at Ridgeline Therapeutics discuss best practices and considerations for leveraging your pre-IND meeting and submitting …
…
continue reading
1
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation
35:52
35:52
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:52
Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.Par Citeline
…
continue reading
1
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen
45:35
45:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
45:35
NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab.https://scrip.citeline.com/SC150328/Ch…
…
continue reading
As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast to learn more about the categories and event itself. (Japanese starts at 2' 25".)English event site: https://www.citeline.com/en/awards/citelinejapanawardsJapanese event site: https://www.citeline.com/…
…
continue reading
1
Scrip's Five Must-Know Things - 27 May 2024
16:00
16:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:00
Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acquisition; AstraZeneca looks to cement respiratory lead; why US FTC is tough on pharma; the US election’s impact on pharma; and how new AI tools are impacting medical affairs.https://scrip.citeline.com/SC1…
…
continue reading
1
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock
23:09
23:09
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
23:09
Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to require patent licensees create plans to ensure access to the commercialized product (7:29), and lawmakers longing for the days when Janet Woodcock ran the FDA’s Center for Drug Evaluation and Research (…
…
continue reading
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies( 邦題意訳:GLP-1を超える心代謝系治療薬のヒントは、冬眠するリスか、地道な運動か)」(日本語版)https://www.citeline.com/ja-jp/resources/hibernating-squirrels-and-exercise-in-a-pill※全文の閲覧には情…
…
continue reading
1
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing
25:21
25:21
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:21
In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairing software and predictive analytics with medications old and new to tailor drug dosing to each patient.Par Citeline
…
continue reading
1
Leading PRO Discusses Plans For Administering State EPR Programs
36:59
36:59
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
36:59
In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility laws launching next year. With a 1 July deadline to register for his PRO, Circular Action Alliance, Hite discusses steps companies should take now, how his organization will assist producers and expectat…
…
continue reading
빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150256/Development-Versus-Dealmaking-How-To-Obtain-A-BlockbusterPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniPar Citeline
…
continue reading
1
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
32:07
32:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:07
In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strategy. Having grown the company with widely successful European OTC medical devices like Dr. Yglo, FungeX and Kidsner, Swane is perfectly placed to explain how to create and grow OTC brands. Swane also o…
…
continue reading
1
Scrip's Five Must-Know Things - 20 May 2024
16:55
16:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:55
Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; blockbusters by indication; gene therapy struggles; sun shines on AstraZeneca and GSK; and Korean ventures look to Japan.https://scrip.citeline.com/SC150281/Quick-Listen-Scrips-Five-MustKnow-ThingsPla…
…
continue reading
1
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation
38:55
38:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
38:55
Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would improve clinical trial diversity with tougher enforcement of the regulation (22:26), as some have suggested, and the FDA’s use of platform technology ideas for gene therapies not participating in the …
…
continue reading
1
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma
16:04
16:04
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
16:04
Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZX…
…
continue reading
1
Ep 87 May 2024 Fourth Circuit Update
31:23
31:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:23
Jonathan Byrne and Josh Carpenter of the Western District of North Carolina Federal Public Defender Office discuss recent Fourth Circuit news.
…
continue reading
1
Ep 86 April 2024 Fourth Circuit and Supreme Court Update
33:25
33:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
33:25
Jonathan Byrne and Alicia Penn of the District of South Carolina Federal Public Defender Office discuss recent Fourth Circuit and Supreme Court news.
…
continue reading
1
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)
35:28
35:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:28
In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from the Pink Sheet in the US, discuss the planned US BIOSECURE Act and markup vote. Brian and Dexter also look at recent R&D updates from Chinese biopharma firms on their antibody-drug conjugate pipelines…
…
continue reading
1
Scrip's Five Must-Know Things - 13 May 2024
14:29
14:29
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:29
Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria farewell; the next wave of cardiometabolics; Pfizer recruits prominent analyst: foundation pleas for China rare disease therapies; and Gossamer partners up for respiratory therapy.https://scrip.citeline.…
…
continue reading
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operation…
…
continue reading
1
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta
29:28
29:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
29:28
In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medicines packaging. Perrotta works for PA Consulting, which set up the Blister Pack Collective alongside consumer healthcare partners Haleon, Bayer and Sanofi. They are working with PulPac, which has inven…
…
continue reading
1
Scrip's Five Must-Know Things - 7 May 2024
15:01
15:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
15:01
Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncology firm; strong growth but supply issues for Lilly; Novo and Lilly make their money work; BMS cuts jobs, costs; and Big Pharma’s support for bioventures.https://scrip.citeline.com/SC150211/Quick-Listen-…
…
continue reading
1
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review
31:23
31:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:23
Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’s efforts to help the clinical trial modeling and simulation industry (16:22), and the UK’s MHRA plan to use artificial intelligence to assist in drug application reviews (21:05).More On These Topics From…
…
continue reading
1
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch
6:35
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft framework on AI, BD’s CTO Beth McCombs R&D initiatives and HSS spine co-chair Sheeraz Qureshi on his vision for integrating AI tech. Hannah Daniel discusses the FDA’s new initiative to create an idea lab for me…
…
continue reading
1
April Datamonitor Podcast 2024: AAN coverage
51:54
51:54
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
51:54
Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN.Other platforms (in addition to SoundCloud):Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vy…
…
continue reading
1
28.04.2024 - Jean 15:18-Jean 16:7 - Un Autre Monde(Frederic Dalais)
42:33
42:33
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
42:33
28.04.2024 - Jean 15:18-Jean 16:7 - Un Autre Monde(Frederic Dalais) by La CitéPar La Cité
…
continue reading
1
21.04.2024 - Jean 15:1-17 - Jesus The True Vine (Simona Vilcu)
47:17
47:17
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
47:17
21.04.2024 - Jean 15:1-17 - Jesus The True Vine (Simona Vilcu) by La CitéPar La Cité
…
continue reading
1
14.04.2024 - Jean 14:14-31 - Promesse de Jésus d’Envoyer Un Autre Défenseur (Frederic Dalais)
29:07
29:07
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
29:07
14.04.2024 - Jean 14:14-31 - Promesse de Jésus d’Envoyer Un Autre Défenseur (Frederic Dalais) by La CitéPar La Cité
…
continue reading
1
07.04.2024 - Jean 14:1-14 (Frederic Dalais)
38:20
38:20
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
38:20
07.04.2024 - Jean 14:1-14 (Frederic Dalais) by La CitéPar La Cité
…
continue reading
1
31.03.2024 - Message de Pacques (Nathan de l'église Fireplace)
44:12
44:12
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
44:12
31.03.2024 - Message de Pacques (Nathan de l'église Fireplace) by La CitéPar La Cité
…
continue reading
1
Scrip's Five Must-Know Things - 30 April 2024
14:15
14:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
14:15
Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drugs and the COVID cliff; falling sales force Roche to reassess priorities; Phase III immunology win for Sanofi; BMS’s strong pipeline: and which companies could be acquired next.https://scrip.citeline.com…
…
continue reading
2024 Global Generics & Biosimilars Awards by CitelinePar Citeline
…
continue reading
1
Podcast: Facilitating Patient Monitoring in CAR-T Development
19:28
19:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:28
Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.Listen in on the conversation as experts fro…
…
continue reading
1
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
34:14
34:14
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
34:14
Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upcoming guidance on accelerated approval for gene therapies (14:15), and partisan attacks on the agency from Capitol Hill (27:13).More On These Topics From The Pink SheetRx Advertising: Interchangeabili…
…
continue reading
1
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session
10:15
10:15
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
10:15
Pulmonologist Bing Xue, MD, reviews the latest GOLD guidelines and discusses relevant topics regarding COPD treatment.Par Citeline
…
continue reading
1
China Biotech Podcast - 26 April 2024 (Chinese and English Language)
28:19
28:19
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
28:19
Join Scrip's China-based editors Brian Yang and Dexter Yan in this Chinese/English podcast as they look at data presented to AACR by Chinese pharma firms and recent acquisitions of China-based companies. UK-based writer Andrew McConaghie also joins to provide his perspectives, including on the proposed US BIOSECURE Act.https://scrip.citeline.com/SC…
…
continue reading
1
Future Governance & Oversight of the EU Medtech Regulatory System
55:58
55:58
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
55:58
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.Par Citeline
…
continue reading
1
Citeline - Cerba Research Podcast V2
19:28
19:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:28
Citeline - Cerba Research Podcast V2 by CitelinePar Citeline
…
continue reading